ArticleOrphanet journal of rare diseases2025
Clinical and genetic analyses of 17 Chinese patients with glycogen storage disease type IXc.
Article in Orphanet journal of rare diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
backgroundGlycogen storage disease type IXc (GSD IXc) is an ultra-rare disorder impairing liver glycogen degradation, caused by a defect in phosphorylase kinase (PhK) γ subunit in the liver encoded by PHKG2. We aim to investigate the clinical, biochemical, genetic, therapeutic, and follow-up characteristics of 17 GSD IXc patients.
methodsMedical records were retrieved, focusing on clinical (height, complications etc.), biochemical [blood glucose, liver transaminases, chitotriosidase (Chit), etc.], genetic, treatment, and follow-up data for 17 patients (8 males, 9 females) with GSD IXc including 16 pediatric patients and one adult.
resultsAbdominal distension (16/16), hypoglycemia (16/16), muscular weakness (12/16), and short stature (5/16) were among the most common presenting features in 16 pediatric patients. At first visit, all 16 pediatric patients showed increased alanine aminotransferase and aspartate aminotransferase. Elevated gamma-glutamyl transferase, triglyceride, lactate, uric acid and total cholesterol were found in 15/15, 10/14, 7/13, 7/14 and 2/14 pediatric patients, respectively. Creatine kinase levels were within normal range in 14/14 patients. The adult patient was diagnosed with liver cirrhosis on her first visit at 36 years. Five out of sixteen pediatric patients achieved hepatomegaly remission after 8.6 ± 4.0 years of uncooked cornstarch (UCCS). The standard deviation scores for ΔHeight in 16 pediatric patients increased from - 1.76 ± 1.16 to 0.05 ± 1.02 (p < 0.0001). Significant improvements were observed in preprandial blood glucose levels and liver transaminases (all p < 0.05). Elevated Chit levels at an early stage of therapy decreased with UCCS [44.47 (9.52, 70.03) to 8.22 (6.37, 18.89) nmol/ml/h, p = 0.02]. One girl received liver transplantation and her clinical manifestations were greatly improved. Eighteen PHKG2 variants were identified, including twelve novel variants and one recurrent variant [c.469G > A, p.E157K (allele frequency: 11/34, 32.4%)]. The c.96-11G > A variant was found to cause a 9 bp retention on the right-hand side of intron 1. Patients with biallelic nonnull variants showed better response to UCCS therapy compared to those with null variants.
conclusionThis study expanded the clinical and variant spectrums of GSD IXc. Chit might be used as a biomarker for monitoring the treatment. Differential response to UCCS therapy based on variant type suggest a genotype-phenotype correlation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.